ACTB and Fabry disease: The results showed interactions between ACTB and PFN1-NOS3 or eNOS as well as the complement pathway suggesting their potential role as biomarkers of the molecular pathology of Fabry disease: ACTB is involved in the eNOS regulation [69], and PFN1 participates in actin polymerization as well as VCL.